The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers
Clinical trial NCT03247140 · COMPLETED
Trial details
- NCT number
- NCT03247140
- Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-10
- Primary completion
- 2017-08-07
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.